The diagnostic value of circulating tumor cells and ctDNA for gene mutations in lung cancer

PURPOSE: Detecting gene mutations by two competing biomarkers, circulating tumor cells (CTCs) and ctDNA has gradually paved a new diagnostic avenue for personalized medicine. We performed a comprehensive analysis to compare the diagnostic value of CTCs and ctDNA for gene mutations in lung cancer. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Mengyuan, Zhou, Jian, Ning, Kang, Ying, Binwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454989/
https://www.ncbi.nlm.nih.gov/pubmed/31040697
http://dx.doi.org/10.2147/OTT.S195342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454989/
https://www.ncbi.nlm.nih.gov/pubmed/31040697
http://dx.doi.org/10.2147/OTT.S195342

Ejemplares similares